Details for 2017816489

Up to date per 01.04.2026

Actions

Title / Product Name

NATIVE OMV-ANTIGEN-KONJUGATE UND DEREN VERWENDUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017816489

EP Publication Number

3544637

E-Number

1332836

Language

PCT Number

EP17080151

Publication Date

02.10.2019 A

11.11.2020 B1

Registration Date

11.11.2020

AT Publication Date

15.11.2020

Application Date

23.11.2017

Registration Number

Priorities

25.11.2016

201619949

27.07.2017

201712101

IPC

A61K 47/69 20170101AFI20200511BHEP

Maximum Duration of Protection

23.11.2037

Owner

GlaxoSmithKline Biologicals S.A.Rue de l'Institut, 89 1330 RixensartBE

Representative

SONN & PARTNER PatentanwälteRiemergasse 141010 WIENAT

Inventor

DI BENEDETTO, RobertaGSK Vaccines Institute for Global Health S.r.l. Via Fiorentina 1 53100 SienaIT

MICOLI, FrancescaGSK Vaccines Institute for Global Health S.r.l. Via Fiorentina 1 53100 SienaIT

SAUL, Allan JamesGSK Vaccines Institute for Global Health S.r.l. Via Fiorentina 1 53100 SienaIT

Information about Fees